Gene News and Research

Latest Gene News and Research

New UCLA study reveals why people with autism experience neural stem cell overgrowth after birth

People with autism spectrum disorder often experience a period of accelerated brain growth after birth. No one knows why, or whether the change is linked to any specific behavioral changes.

10 Oct 2014

Neurobiologist Michael Meaney wins 2014 Klaus J. Jacobs Research Prize

Neurobiologist Michael Meaney (McGill University and Douglas Mental Health University Institute), a senior fellow of the Canadian Institute for Advanced Research, has won a major award worth $1.16 million Canadian for his research on how early childhood experiences shape biological development.

10 Oct 2014

Isis Pharmaceuticals provides update on Phase 2 clinical studies of ISIS-SMN Rx in children with SMA

Isis Pharmaceuticals, Inc. today provided an update on its ongoing open-label Phase 2 clinical studies of ISIS-SMN Rx in infants and children with spinal muscular atrophy at the 19th International World Muscle Society (WMS) Congress in Berlin, Germany.

10 Oct 2014

UChicago awarded $12 million grant to establish national center to study drug abuse-related behaviors

The National Institute on Drug Abuse has awarded the University of Chicago a $12 million, five year grant to establish a national Center of Excellence to study drug abuse-associated behaviors by conducting research with rats.

10 Oct 2014

CUMC researchers use innovative algorithm to find driving force behind aggressive form of glioblastoma

Using an innovative algorithm that analyzes gene regulatory and signaling networks, Columbia University Medical Center researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.

10 Oct 2014

Study addresses the challenge of genomic heterogeneity

Known cancer-driving genomic aberrations in localized lung cancer appear to be so consistently present across tumors that a single biopsy of one region of the tumor is likely to identify most of them, according to a paper published today in Science.

10 Oct 2014

Scientists use novel way to identify new gene linked to Alzheimer's

Scientists at The University of Manchester have used a new way of working to identify a new gene linked to neurodegenerative diseases such as Alzheimer's. The discovery fills in another piece of the jigsaw when it comes to identifying people most at risk of developing the condition.

From The University of Manchester 10 Oct 2014

CTCs in blood of metastatic cancer patients give genomic read-out of breast cancer

The genetic fingerprint of a metastatic cancer is constantly changing, which means that the therapy that may have stopped a patient's cancer growth today, won't necessarily work tomorrow.

9 Oct 2014

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal.

9 Oct 2014

Specific perceptual learning deficit associated with Fragile X Syndrome

Researchers at Children's Hospital Los Angeles have described for the first time a specific perceptual learning deficit in mice with a mutation of the same gene as found in children with Fragile X Syndrome (FXS).

9 Oct 2014

BRCA mutations carry risks for salivary gland cancer, breast cancer

The risk of developing cancer in a salivary gland might be higher in people with mutations in either of two genes associated with breast and ovarian cancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

9 Oct 2014

UCI to receive $8 million from NIH to study brain cell activity in motor neuron disorders

UC Irvine will receive $8 million from the National Institutes of Health to establish one of six national centers dedicated to creating a database of human cellular responses that will accelerate efforts to develop new therapies for many diseases.

9 Oct 2014

AT2101 drug, evaluated for Gaucher disease, slows progression of Parkinson's disease in mice

A new study from UCLA found that a drug being evaluated to treat an entirely different disorder helped slow the progression of Parkinson's disease in mice.

9 Oct 2014

Researchers generate fruit fly model, unveil key genetic factors behind human colon cancer

Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have managed to generate a fruit fly (Drosophila melanogaster) model that reproduces human colon cancer. With two publications appearing in PLoS One and EMBO Reports, the IRB team also unveil the function of a key gene in the development of the disease.

9 Oct 2014

NF-kB molecule may help malignant cells hide from the immune system

A molecule that helps cancer cells evade programmed self-destruction, an internal source of death, might also help malignant cells hide from the immune system, an external source of death.

8 Oct 2014

GeneSolve to license its health optimization system to highly qualified doctors

GeneSolve announced today that it will begin licensing its proprietary health optimization system to a network of highly qualified doctors nationwide.

7 Oct 2014

New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies

New England Biolabs, Inc. (NEB®) has strengthened its position as a key supplier to the fast-growing RNA synthesis market by signing an agreement to supply critical reagents to TriLink BioTechnologies, Inc., a leading manufacturer of mRNA and long RNA for research, diagnostic and therapeutic applications.

From New England Biolabs 7 Oct 2014

Scientists identify new biomarker for diagnosing cause of thyroid cancer

The expression of the protein CLIP2 provides information on whether a papillary thyroid carcinoma was induced by radiation or had a sporadic origin. With this discovery, scientists from the Helmholtz Zentrum München have identified a new biomarker for the diagnosis of the cancer cause.

7 Oct 2014

USC scientists find new way to suppress obesity

Imagine being able to take a pill that lets you eat all of the ice cream, cookies, and cakes that you wanted – without gaining any weight.

7 Oct 2014

Vesicles play significant role in the functioning of neurons

Tiny vesicles containing protective substances which they transmit to nerve cells apparently play an important role in the functioning of neurons. As cell biologists at Johannes Gutenberg University Mainz (JGU) have discovered, nerve cells can enlist the aid of mini-vesicles of neighboring glial cells to defend themselves against stress and other potentially detrimental factors.

7 Oct 2014

Gene News and Research

Latest Gene News and Research

New UCLA study reveals why people with autism experience neural stem cell overgrowth after birth

Neurobiologist Michael Meaney wins 2014 Klaus J. Jacobs Research Prize

Isis Pharmaceuticals provides update on Phase 2 clinical studies of ISIS-SMN Rx in children with SMA

UChicago awarded $12 million grant to establish national center to study drug abuse-related behaviors

CUMC researchers use innovative algorithm to find driving force behind aggressive form of glioblastoma

Study addresses the challenge of genomic heterogeneity

Scientists use novel way to identify new gene linked to Alzheimer's

CTCs in blood of metastatic cancer patients give genomic read-out of breast cancer

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

Specific perceptual learning deficit associated with Fragile X Syndrome

BRCA mutations carry risks for salivary gland cancer, breast cancer

UCI to receive $8 million from NIH to study brain cell activity in motor neuron disorders

AT2101 drug, evaluated for Gaucher disease, slows progression of Parkinson's disease in mice

Researchers generate fruit fly model, unveil key genetic factors behind human colon cancer

NF-kB molecule may help malignant cells hide from the immune system

GeneSolve to license its health optimization system to highly qualified doctors

New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies

Scientists identify new biomarker for diagnosing cause of thyroid cancer

USC scientists find new way to suppress obesity

Vesicles play significant role in the functioning of neurons

eBook: Using iPSCs models for human disease research and drug discovery eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research